Oncology
For years, Sara worked in a hospital, making care possible for others. Now, after being diagnosed with breast cancer, she was the one in need of care.
Parexel on the Pulse: EU Clinical Trial Regulation (CTR)
Paul Bridges on the EU Clinical Trial Regulation (CTR)
Related Insights
Blog
Assessing the need for comparative clinical trials in biosimilar development programs
Sep 21, 2023
Article
Expedited Pathways Comparisons - US EU CHN
Oct 19, 2021
Article
New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle
May 10, 2022
Video
On-demand webinar: An expert guide to EU-CTR
Mar 10, 2022
Article
New endpoints for early-stage cancer are gaining regulatory traction
Jan 28, 2022
Video
Creating EU-CTR compliant and patient-friendly lay language summaries (LLS)
Jan 26, 2022
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
Biosimilar Development: Are therapeutic clinical trials needed?
Nov 16, 2021
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Video
Overcoming asset transfer challenges during a merger and acquisition (M&A)
Oct 20, 2021
Article
Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct
Sep 14, 2021